key: cord-0873157-4irma9o8
authors: Duverger, C.; Souyri, V.; Monteil, C.; Fournier, S.
title: Controlling healthcare-associated transmission of SARS-CoV-2 Variant of Concern 202012/01 in a large hospital network
date: 2021-05-07
journal: J Hosp Infect
DOI: 10.1016/j.jhin.2021.04.031
sha: f2f01de5e246ad2ea5fc4f98ff1a7504819d7510
doc_id: 873157
cord_uid: 4irma9o8

nan

Many SARS-CoV-2 hospital outbreaks have been reported worldwide, involving patients and/or healthcare workers (HCWs) [1, 2] . The variant of concern 202012/01 (VOC-202012/01) lineage B.1.1.7, responsible for an important epidemic resumption in the UK in November 2020, seems to be more transmissible [3] and more lethal [4] than the preexisting SARS-CoV-2 variants (non-VOC). In the current context of the emergence of this new variant in France [5] , the aim of this observational study was to assess whether transmission control measures were effective to control hospitals VOC-202012/01 outbreaks. is also promoted. HCWs and patients experiencing contact without medical mask with a confirmed COVID-19 case are tested for SARS-CoV-2, even if asymptomatic, with repeated screening at Day 7.

Outbreak control measures include weekly screening of asymptomatic patients and HCWs contacts, cohorting of patients' cases and furloughing HCWs' cases for 10 days, stopping visits and joint activities, and reinforcing COVID-19 prevention transmission measures.

A case was defined as any patient or HCW with a positive SARS-CoV-2 reverse transcriptase polymerase chain reaction (RT-PCR). A VOC-202012/01 case was defined as any case with specific mutations identified through specific RT-PCR or genotyping of spike protein gene [6] . An outbreak was defined as at least two cases (patients and/or HCWs) linked by time (within 7 days), geographic location and possible contact. An outbreak was considered controlled after 14 days without new cases.

For each outbreak from December 20th, 2020 (first outbreak with VOC-202012/01 in AP-HP hospitals) to February 21st, 2021, the following data were collected: variants type, number of cases This study has several limitations, including the lack of sequencing completeness. Another limitation is that we did not assess HCWs compliance with the prevention measures, which could have been more rigorous with VOC-202012/01 cases, although the time frame in which the sequencing results were available makes this unlikely. By contrast, that contact screening of exposed HCWs and patients may have been more extensive due to the fear of rapid dissemination of VOC-202012/01 could explain a higher number of cases in VOC-202012/01 outbreaks, thus reinforcing that the transmission of VOC was not higher than of non-VOC in our hospital network. Unfortunately, we could not collect the number of screened individuals in both groups.

Finally, despite its higher transmissibility and its rapid spread in France, our results suggest that the VOC-202012/01 was not associated with higher intra hospital diffusion comparing with non-VOC in our hospital network, thanks to strict infection control measures. 

Nosocomial transmission and outbreaks of coronavirus disease 2019: the need to protect both patients and healthcare workers

Transmission of SARS-CoV-2 among healthcare workers and patients in a teaching hospital in the Netherlands confirmed by whole-genome sequencing

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: Matched cohort study

Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France

Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a wholegenome sequencing and hospital-based cohort study

*Members of the AP-HP COVID-19 Infection Control Group F. Espinasse, MC. Gramer, Hôpital Ambroise Paré